Valuation: Clover Corporation Limited

Market Cap 164M 116M 100M 93.95M 85.69M 161M 11.04B 1.11B 432M 5.53B 435M 425M 18.43B P/E 2026 *
16.8x
P/E 2027 * 12.2x
Enterprise Value 161M 114M 98.86M 92.63M 84.49M 159M 10.88B 1.09B 426M 5.45B 428M 419M 18.17B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.35x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.50%
1 week+4.79%
Current month+2.60%
1 month+30.46%
3 months+3.41%
6 months+25.48%
Current year+24.68%
1 week 0.93
Extreme 0.93
1
1 month 0.76
Extreme 0.76
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
11/18/25 A Sell

Chief Executive Officer

255,199 0.1528%
11/18/25 A Buy

Chief Executive Officer

529,638 0.3171%
11/6/25 A Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+4.79%+74.34%-7.51% 117M
+0.86%+1.83%+35.66%+88.21% 13.83B
-1.29%+14.43%-15.16%+316.40% 8.94B
+1.50%-1.17%-20.42%-49.80% 2.48B
+3.56%+15.94%-12.74%-12.83% 1.45B
-0.26%+9.95%+23.12%+69.75% 1.36B
-7.27%-14.00%-72.01%-71.87% 1.34B
+0.04%-6.75%+28.28%-30.96% 1.23B
+0.16%+0.05%-36.93% - 1.14B
-0.32%-3.00%-62.72%-70.54% 961M
Average -0.44%+1.60%-5.86%+25.65% 3.28B
Weighted average by Cap. -0.03%+2.46%+5.02%+119.78%

Financials

2026 *2027 *
Net sales 94M 66.51M 57.62M 53.99M 49.24M 92.58M 6.34B 635M 248M 3.18B 250M 244M 10.59B 116M 82.14M 71.17M 66.68M 60.82M 114M 7.83B 784M 307M 3.92B 308M 302M 13.08B
Net income 9.8M 6.93M 6.01M 5.63M 5.13M 9.65M 661M 66.2M 25.88M 331M 26.03M 25.47M 1.1B 13.5M 9.55M 8.28M 7.75M 7.07M 13.3M 911M 91.19M 35.65M 456M 35.86M 35.08M 1.52B
Net Debt -2.3M -1.63M -1.41M -1.32M -1.2M -2.27M -155M -15.54M -6.07M -77.71M -6.11M -5.98M -259M -7.2M -5.09M -4.41M -4.14M -3.77M -7.09M -486M -48.64M -19.01M -243M -19.13M -18.71M -811M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
12/08/26 A$0.9850 -1.50% 71,539
11/08/26 A$1.000 +1.01% 49,144
10/08/26 A$0.9900 +3.13% 151,019
07/08/26 A$0.9600 0.00% 10,011
06/08/26 A$0.9600 0.00% 24,381
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9850AUD
Average target price
1.280AUD
Spread / Average Target
+29.95%

Annual profits - Rate of surprise